Dr. Marek Wasiluk, CEO and Founder of CLINMARK, is a seasoned clinical-trials leader with 25+ years of global experience driving innovative research across emerging markets. A DMD-MBA professional, ISO 9001 Lead Auditor, and lecturer at Warsaw Medical University, he has overseen 400+ trials in 75+ countries while also building ventures like L’experta and Wasiluk Consulting, establishing a reputation for precision, quality, and execution in modern clinical research.
Building a Smarter Clinical Research Partner
Early in his career, Dr. Wasiluk witnessed both the power of well-run trials and the frustration of unnecessary complexity in clinical research. “That combination convinced me there was room for a different kind of partner in this industry,” he recalls. From the beginning, his ambition was to build what he describes as a “brain CRO” – an organisation driven not only by operational capacity, but by expertise, strategic thinking, and the ability to guide clients in making the right decisions in a complex global environment. This idea ultimately became the foundation for CLINMARK.
He describes CLINMARK’s early days as a small, highly specialised team built on strong expertise in monitoring, audits, and quality management, guided by a simple ambition: to run projects better, smarter, and more thoughtfully than the prevailing market standard. Over time, through a consistent focus on quality, GxP audits, and international collaboration, the company evolved into a trusted global partner delivering hundreds of clinical studies and consulting projects worldwide.
Dr. Wasiluk’s leadership philosophy is grounded in several clear principles: responsibility for quality, transparency with clients and teams, and a belief that strong leadership should simplify complex processes rather than add unnecessary layers. “I see my role as enabling people and organisations to perform at their best,” he explains. “That means setting a clear direction, offering honest and demanding feedback, and creating an environment where teams can grow, make decisions, and take responsibility in complex clinical and audit projects.”
Leadership, Continuous Growth, and Resilience
Dr. Wasiluk believes that credibility in life sciences begins with leadership accountability. “In life sciences, a company’s credibility is inseparable from the credibility of its leaders,” he notes, emphasizing that stakeholders ultimately judge whether commitments to ethics and quality are reflected in how projects are actually managed.
For him, leadership also means fostering an environment of continuous growth. Dr. Wasiluk strongly believes that in a rapidly evolving world and industry, standing still is not an option. He places great value on learning, adaptability, and development – both for himself and for the entire team. By creating opportunities for professional growth and encouraging people to expand their skills, he aims to help the team stay responsive to a changing market while also enabling individuals to develop in ways that are meaningful to them personally.
Dr. Wasiluk approaches challenges with a positive and open mindset, seeing them as opportunities to learn, improve, and strengthen the organization. He values flexibility, curiosity, and resilience, believing that these qualities allow both leaders and teams to navigate uncertainty while continuing to evolve.
Scaling Without Losing Craftsmanship
For Dr. Wasiluk, the toughest part of scaling CLINMARK was protecting the craftsmanship-level quality and individual approach that defined its early years while pursuing rapid growth. The company addressed this by building a robust quality system, strengthening audit and CAPA culture, and investing in experts who could replicate high standards across new teams, services, and regions.
On staying client-focused while innovating, Dr. Wasiluk notes that the company operates as “a strategic partner, not a transactional vendor,” working with clients to co-design development strategies, market plans, and risk approaches. CLINMARK continues to innovate in processes such as audits, due diligence, and regulatory pathways so that, as the company grows, clients feel it evolves alongside them and helps them stay ahead.
A Smart Global Vision for Growth
Dr. Wasiluk notes that working with international teams and emerging markets has significantly shaped how CLINMARK approaches clinical research. In his view, success depends not only on protocol design, but also on a deep understanding of local healthcare realities, site culture, and regulatory expectations. This perspective has led him to position CLINMARK not just as a service provider, but as an intelligent advisor to its clients.
Dr. Wasiluk believes that the role of the company is to support clients in making thoughtful, well-informed decisions about how and where to move forward with their projects. Rather than following rigid, predefined models that are often considered “standard,” CLINMARK focuses on flexible thinking and careful analysis of multiple factors. The goal is to identify the most effective paths for market entry, study execution, and long-term development by adapting strategies to changing market conditions and opportunities.
He has therefore built a “smart global” approach that combines operational flexibility, market-entry insight, and global GCP standards applied pragmatically to local practice. By taking this adaptive and strategic perspective, CLINMARK aims to help clients navigate complexity while making the most of emerging opportunities.
Looking ahead, Dr. Wasiluk sees CLINMARK’s mission as supporting clients not only in executing clinical research projects, but in achieving their broader business goals. For him, true partnership means ensuring that the work ultimately delivers meaningful outcomes—helping clients bring their innovations forward successfully and translate their plans into real, measurable impact.
Conclusion
For Dr. Marek Wasiluk, leadership in clinical research means taking responsibility for direction and decisions that truly matter. With more than 25 years of global experience, he serves as a trusted guide for both the CLINMARK team and the clients who rely on his expertise when navigating complex clinical and regulatory environments. His role is not only to lead, but also to ensure that strategies and projects move in the right direction and lead to meaningful success.
With more than two decades of international experience, he has become a trusted voice for both his team and the clients who rely on his guidance when navigating critical strategic choices. Dr. Wasiluk sees his role as a guarantor of credibility, thoughtful decision-making, and long-term success. Whether leading the CLINMARK team or advising companies on clinical development strategies, he focuses on providing clarity, perspective, and direction. His approach combines strategic thinking with a practical understanding of regulatory, operational, and market realities, allowing organisations to move forward with confidence.
Alongside his work as a CEO and advisor, Dr. Wasiluk is deeply committed to education and mentoring. As a lecturer, he focuses on explaining complex clinical research and regulatory topics in a clear and practical way—something especially valuable in a field as intricate as clinical research. Through teaching, coaching skills, and knowledge sharing, he supports the growth of both teams and industry professionals, helping them make better decisions with confidence.
